Nitric oxide (NO) donor 3-morpholinosydnonimine antagonizes cyclosporin A-induced contraction in two in vitro glomerular models

Cell Biology and Toxicology

Volumn 12, Issue 4-6, 1996, Pages 335-339

  Potier, M ^a   Winicki, J ^b   Cambar, J ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b Laboratoires Hoechst   (France)

Author keywords

contraction; cyclosporin A; isolated glomeruli; mesangial cells; SIN 1

Indexed keywords

CYCLOSPORIN A; LINSIDOMINE;

ANIMAL CELL; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ANTAGONISM; GLOMERULUS; IN VITRO STUDY; MESANGIUM CELL; MODEL; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL ADHESION; CELL SIZE; CELLS, CULTURED; CYCLOSPORINE; ENZYME INHIBITORS; GLOMERULAR MESANGIUM; IMAGE PROCESSING, COMPUTER-ASSISTED; KIDNEY GLOMERULUS; MOLSIDOMINE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NITRIC OXIDE; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; GLOMERULUS;

EID: 0029802549     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00438167     Document Type: Conference Paper

References (15)

1. Ardaillou R, Sraer J, Chansel D, Ardaillou N, Sraer JD. The effect of angiotensin II on isolated glomeruli and cultured mesangial cells. Kidney Int. 1987; 31:S74-80.
2. Borenfreund E, Puerner JA. Toxicity assessed in vitro by morphological alterations and neutral red absorption. Toxicol Lett. 1985;24:119-24.
3. Garg UC, Hassid A. Inhibition of rat mesangial cells mitogenesis by nitric oxide generating vasodilatators. Am J Physiol. 1989;257:F60-6.
4. Gonzalez R, Redon P, Lakhdar B, Potaux L, Cambar J, Aparicio M. Cyclosporine nephrotoxicity assessed in isolated human glomeruli and cultured rat mesangial cells. Toxicol In Vitro. 1990;4:391-5.
5. L'Azou B, Cambar J. Prevention of cyclosporin-induced vasoconstrictive effect in rat isolated glomeruli with pharmacological vasoactive agents. Toxicol In Vitro. 1993;7:417-20.
6. Loveland BE, Johns TG, Mackay IR, Vaillant F, Wang ZX, Hertzog PJ. Validation of the MTT dye assay for enumeration of cells in proliferative and antiproliferative assays. Biochem Int. 1992;27:501-10.
7. Luscher TF. Possibilities and perspectives of pharmacotherapy for endothelial protection. Curr Opin Nephrol Hypertens. 1993;2:129-36.
8. Moncada S, Palmar RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991; 43:109-42.
9. Pfeilschifter J. Cross-talk between transmembrane signalling systems: a prerequisite for the delicate regulation of glomerular haemodynamics by mesangial cells. Eur J Pharmacol. 1990;19:347-61.
10. Potier M, Lakhdar B, L'Azou B, Cambar J. Evidence for a protective effect of theophylline and caffeine on cyclosporin induced contraction in two in vitro glomerular models. Transplant Proc. 1995;27:2492-4.
11. Raij L, Shultz PJ. Endothelium derived relaxing factor, nitric oxide: effects on and production by mesangial cells and the glomerulus. J Am Soc Nephrol. 1993;3:1435-41.
12. Rodriguez-Puyol D, Lamas S, Olivera A et al. Actions of cyclosporine on cultured rat mesangial cells. Kidney Int. 1989;35:632-7.
13. Romero JC, Strick DM. Nitric oxide and renal function. Curr Opin Nephrol Hypertens. 1993;2:114-21.
14. Schror K, Forster S, Woditsch I, Schroder H. Generation of NO from molsidomine (SIN-1) in vitro and its relationship to changes in coronary vessels tone. J Cardiovasc Pharmacol. 1989;14:S29-34.
15. Wolf A, Clemann N, Friehauff W, Ryffel B, Cordier A. Role of reactive oxygen formation in the cyclosporin A mediated impairment of renal functions. Transplant Proc. 1994;16: 2902-7.